Michael Mouradian, Ph.D.
|2013||Biochemistry||University of Nevada, Reno, Reno, NV, United States|
Area:Biochemistry, Molecular Biology, Nutrition
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Mouradian M, Ma IV, Vicente ED, et al. (2016) Docosahexaenoic Acid-mediated Inhibition of Heat Shock Protein 90-p23 Chaperone Complex and Downstream Client Proteins in Lung and Breast Cancer. Nutrition and Cancer. 1-13|
|Mouradian M, Kikawa KD, Dranka BP, et al. (2015) Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function. Molecular Carcinogenesis. 54: 810-20|
|Mouradian M, Kikawa KD, Johnson ED, et al. (2014) Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 90: 105-15|
|Kikawa KD, Herrick JS, Tateo RE, et al. (2010) Induced oxidative stress and cell death in the A549 lung adenocarcinoma cell line by ionizing radiation is enhanced by supplementation with docosahexaenoic acid. Nutrition and Cancer. 62: 1017-24|
|Rogers KR, Kikawa KD, Mouradian M, et al. (2010) Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis. 31: 1523-30|